Best Vitamin B12 Supplements for GLP-1 Fatigue (2026 Reviewed)

Vitamin B12 (cobalamin) participates in two critical biochemical reactions in the human body. As methylcobalamin, it is required for the conversion of homocysteine to methionine — a reaction central to DNA synthesis, myelin formation (the protective sheath around nerve fibers), and red blood cell maturation. As adenosylcobalamin, it is required for the metabolism of certain fatty acids in mitochondria. Deficiency in either pathway produces fatigue through distinct but overlapping mechanisms: impaired red blood cell maturation leads to megaloblastic anemia and reduced oxygen-carrying capacity; impaired myelin synthesis leads to neurological symptoms including fatigue, brain fog, numbness, and tingling. The standard absorption pathway for dietary B12 is complex and requires multiple steps: gastric acid releases B12 from food proteins; intrinsic factor (produced by gastric parietal cells) binds B12; and the B12-intrinsic factor complex is absorbed at specific receptors in the terminal ileum. GLP-1 medications slow gastric emptying, which may reduce the efficiency of the acid-dependent cleavage step. More significantly, metformin — co-prescribed with high frequency in GLP-1 users being treated for type 2 diabetes or prediabetes — is thought to block the calcium-dependent absorption of the B12-intrinsic factor complex at the ileal receptor, independently of diet or gastric function. This dual impairment, combined with reduced dietary intake from caloric restriction, creates a triple-depletion pathway that is not seen in most other supplement contexts. Sublingual methylcobalamin bypasses the gastric portion of this pathway entirely: absorbed through the oral mucosa into the bloodstream directly, it does not require gastric acid, intrinsic factor, or ileal receptor function. This makes sublingual delivery mechanistically well-suited to the GLP-1 population.

The single most important consideration for B12 supplementation in the GLP-1 population is form and delivery route — not dose alone. If your GLP-1 medication is slowing gastric emptying (as these drugs do by mechanism), and you are also taking metformin (which blocks ileal B12 absorption), a standard swallowed capsule of cyanocobalamin may not reliably deliver B12 to your bloodstream. The gastric processing chain that standard oral B12 relies on may be partially compromised at multiple points. Sublingual methylcobalamin lozenges address this directly: they absorb through the oral mucosa before reaching the stomach, bypassing both gastric acid dependency and the ileal receptor mechanism that metformin disrupts. For GLP-1 users on metformin, sublingual methylcobalamin (options 1 and 2 on this list) is the mechanistically appropriate choice. Methylcobalamin vs. cyanocobalamin: methylcobalamin is the active coenzyme form — it does not require enzymatic conversion and is directly usable by cells. Cyanocobalamin (synthetic) requires enzymatic demethylation to become active; for most healthy adults this conversion is efficient, but for adults with MTHFR variants, impaired conversion, or compromised gastric function, methylcobalamin is the more reliable choice. In cases of significant B12 deficiency — particularly with neurological symptoms — oral supplementation at any dose may not be sufficient. Intramuscular B12 injections (hydroxocobalamin or cyanocobalamin) provide 100% bioavailable repletion and are the standard medical treatment for severe deficiency. If your serum B12 is very low (below 200 pg/mL) or you have neurological symptoms, discuss injection therapy with your physician rather than relying solely on oral supplements.